OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment-Resistant Depression in Real-World Clinical Practice: A Systematic Literature Review of Data from 2012 to 2022
Albino J. Oliveira‐Maia, Ania Bobrowska, Éric Constant, et al.
Advances in Therapy (2023) Vol. 41, Iss. 1, pp. 34-64
Open Access | Times Cited: 11
Albino J. Oliveira‐Maia, Ania Bobrowska, Éric Constant, et al.
Advances in Therapy (2023) Vol. 41, Iss. 1, pp. 34-64
Open Access | Times Cited: 11
Showing 11 citing articles:
Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study
Eduard Vieta, Nahida Ahmed, Celso Arango, et al.
European Neuropsychopharmacology (2025) Vol. 93, pp. 29-39
Open Access | Times Cited: 2
Eduard Vieta, Nahida Ahmed, Celso Arango, et al.
European Neuropsychopharmacology (2025) Vol. 93, pp. 29-39
Open Access | Times Cited: 2
Omega-3 Polyunsaturated Fatty Acids in Depression
Anna Serefko, Monika Elżbieta Jach, Marlena Pietraszuk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8675-8675
Open Access | Times Cited: 13
Anna Serefko, Monika Elżbieta Jach, Marlena Pietraszuk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8675-8675
Open Access | Times Cited: 13
Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USA
Manish K. Jha, Maryia Zhdanava, Aditi Shah, et al.
Drugs - Real World Outcomes (2025)
Open Access
Manish K. Jha, Maryia Zhdanava, Aditi Shah, et al.
Drugs - Real World Outcomes (2025)
Open Access
The Novel Imipramine–Magnesium Complex Exerts Antidepressant-Like Activity in Mice Subjected to the Forced Swim Test and the Tail Suspension Test
Anna Serefko, Joanna Lachowicz-Radulska, Aleksandra Szopa, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 519-519
Open Access
Anna Serefko, Joanna Lachowicz-Radulska, Aleksandra Szopa, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 519-519
Open Access
Intensive Short-Term Dynamic Psychotherapy for Complex, Chronic, and Treatment-Resistant Conditions
Allan Abbass, Joel M. Town
American Journal of Psychotherapy (2025)
Closed Access
Allan Abbass, Joel M. Town
American Journal of Psychotherapy (2025)
Closed Access
A novel antidepressant intervention for outpatient psychiatry
Gryan Garcia
Journal of Prescribing Practice (2025) Vol. 7, Iss. 2, pp. 80-85
Closed Access
Gryan Garcia
Journal of Prescribing Practice (2025) Vol. 7, Iss. 2, pp. 80-85
Closed Access
Advances in repetitive transcranial magnetic stimulation in the treatment of treatment-resistant depression: a comprehensive review
Hui Xing, Xiaolei Liu, Yingying Zhang, et al.
Reviews in the Neurosciences (2025)
Closed Access
Hui Xing, Xiaolei Liu, Yingying Zhang, et al.
Reviews in the Neurosciences (2025)
Closed Access
Characteristics of patients with major depressive disorder eligible for and prescribed esketamine, treatment outcomes and physician experiences: a physician and patient survey in the United States
Manish K. Jha, Amanda Teeple, Jason F. Shepherd, et al.
Current Medical Research and Opinion (2025), pp. 1-14
Closed Access
Manish K. Jha, Amanda Teeple, Jason F. Shepherd, et al.
Current Medical Research and Opinion (2025), pp. 1-14
Closed Access
Treatment-resistant depression and intranasal esketamine: Spanish clinical consensus on practical aspects
Josep Antoni Ramos‐Quiroga, Fernando Mora, Silvia Arostegui, et al.
The European Journal of Psychiatry (2025) Vol. 39, Iss. 3, pp. 100313-100313
Open Access
Josep Antoni Ramos‐Quiroga, Fernando Mora, Silvia Arostegui, et al.
The European Journal of Psychiatry (2025) Vol. 39, Iss. 3, pp. 100313-100313
Open Access
Venlafaxine-plga nanoparticles provide a fast onset of action in an animal model of depression via nose-to-brain
María Dolores Cayero Otero, Laura Pérez-Caballero, Irene Suárez‐Pereira, et al.
International Journal of Pharmaceutics (2025), pp. 125692-125692
Open Access
María Dolores Cayero Otero, Laura Pérez-Caballero, Irene Suárez‐Pereira, et al.
International Journal of Pharmaceutics (2025), pp. 125692-125692
Open Access
Risk factors for suicidal attempts in a sample of outpatients with treatment-resistant depression: an observational study
Serena Chiara Civardi, Filippo Besana, Giovanni Carnevale Miacca, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Serena Chiara Civardi, Filippo Besana, Giovanni Carnevale Miacca, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
The Efficacy of Eye Movement Desensitization and Reprocessing Treatment for Depression: A Meta-Analysis and Meta-Regression of Randomized Controlled Trials
Ji‐Woo Seok, Joong Il Kim
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5633-5633
Open Access
Ji‐Woo Seok, Joong Il Kim
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5633-5633
Open Access
Abnormal choroid plexus, hippocampus, and lateral ventricles volumes as markers of treatment‐resistant major depressive disorder
B. Bravi, Marco Paolini, Melania Maccario, et al.
Psychiatry and Clinical Neurosciences (2024)
Closed Access
B. Bravi, Marco Paolini, Melania Maccario, et al.
Psychiatry and Clinical Neurosciences (2024)
Closed Access
